Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 162

Sort by

Sort Order Select

Journal Articles

Real-world data of adolescents and young adults with acute lymphoblastic leukemia treated with a modified GMALL protocol in India: Treatment outcomes and challenges

Blood (2025) 146 (Supplement 1): 6321.

https://doi.org/10.1182/blood-2025-6321

Published: 2025

Journal Articles

Targeted base editing enables safe and efficient knockout of ELANE for the treatment of ELANE-associated severe congenital neutropenia

Lokesh Panigrahi, Ramyadevi Veerabahu, Eunice Edison, Uday Kulkarni, Biju George, Mohankumar Murugesan

Blood (2025) 146 (Supplement 1): 2993.

https://doi.org/10.1182/blood-2025-2993

Published: 2025

Journal Articles

Impact of cancer and therapy on the epigenetic landscapes of normal cells: Describing a novel biomarker in survivorship

Sushil Selvarajan, Uday Kulkarni, Ramachandran Shaji, Aby Abraham, Anu Korula, Sharon Lionel, Ganesh Jammula, Biju George, Saurabh Agarwal, Vikram Mathews

Blood (2025) 146 (Supplement 1): 1730.

https://doi.org/10.1182/blood-2025-1730

Published: 2025

Journal Articles

Role of fludarabine exposure on post-transplant outcomes in high-risk β-thalassemia patients undergoing allogeneic HCT with thiotepa/ fludarabine/ treosulfan conditioning

Rachel Renji, Aswin PAI, Nayanthara Bijukumar, Ezhilpavai Mohanan, Sujith Karumathil, Uday Kulkarni, John Panetta, Kavitha Lakshmi, Eunice Edison, Aby Abraham, Biju George, Anu Korula, Vikram Mathews, Poonkuzhali Balasubramanian

Blood (2025) 146 (Supplement 1): 2419.

https://doi.org/10.1182/blood-2025-2419

Published: 2025

Journal Articles

Clinico-pathological profile and treatment patterns of immune mediated aplastic anemia in resource constrained settings – an analysis from the aplastic anemia registry of India

Biju George, Arihant Jain, Neeraj Sidharthan, Tuphan Dolai, Rabindra Jena, Chandrakala Shanmukhaiah, Shashikant Apte, Priyanka Samal, Alka Khadwal, Monisha Harimadhavan, Raveen Raj, Rajib De, Dr PRAKAS KUMAR Mandal, Sudha Sethy, Nutan Joshi, Aby Abraham, Pankaj Malhotra, Vikram Mathews

Blood (2025) 146 (Supplement 1): 6253.

https://doi.org/10.1182/blood-2025-6253

Published: 2025

Journal Articles

Higher busulfan cumulative exposure predicts better thalassemia-free survival in patients with beta thalassemia undergoing HCT with busulfan-cyclophosphamide containing conditioning regimen

Poonkuzhali Balasubramanian, Rachel Renji, Jayachitra Aadi, Aswin PAI, Rajesh Nagarajan, Hemamalini Suresh, John Panetta, Kavitha Lakshmi, Eunice Edison, Sujith Karumathil, Aby Abraham, Anu Korula, Uday Kulkarni, Vikram Mathews, Biju George

Blood (2025) 146 (Supplement 1): 4211.

https://doi.org/10.1182/blood-2025-4211

Published: 2025

Journal Articles

Safety, Efficacy and Total Cost of Therapy of Decentralized, Point-of-Care Manufactured Anti-CD19 CAR-T Cells for Relapsed or Refractory B Cell Leukemia and Lymphoma: Results from the First Phase 1 Indian Trial (VELCART)

Palani Hamenth Kumar, Arun Kumar Arunachalam, Mohammed Yasar, Phaneendra Venkateswara Rao Datari, Uday Kulkarni, Sushil Selvarajan, Anu Korula, Aby Abraham, Biju George, Vikram Mathews

Blood (2024) 144 (Supplement 1): 2090.

https://doi.org/10.1182/blood-2024-201902

Published: 2024

Journal Articles

Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification

Aswin Anand Pai, John C Panetta, Nayanthara Bijukumar, Rachel Mariam Renji, Manoj A, Agila Jayaraman, Sujith Karumathil, Anu Korula, Sushil Selvarajan, Alok Srivastava, Aby Abraham, Vikram Mathews, Biju George, Uday Kulkarni, Poonkuzhali Balasubramanian

Blood (2024) 144 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2024-203105

Published: 2024

Journal Articles

Danazol and Stanozolol Induce Expression of Pro-Apoptotic Genes

Rosy Mary Marandi, Biju George, Eunice Sindhuvi Edison

Blood (2024) 144 (Supplement 1): 5686.

https://doi.org/10.1182/blood-2024-207088

Published: 2024

Journal Articles

Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Chirag Trivedi, Sujith Kumar, Sushil Selvarajan, Sharon Anbumalar Lionel, Anup J Devasia, Fouzia N., Uday Kulkarni, Aby Abraham, Alok Srivastava, Biju George, Vikram Mathews, Anu Korula

Blood (2024) 144 (Supplement 1): 3048.

https://doi.org/10.1182/blood-2024-198979

Published: 2024

Journal Articles

Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma

Anu Korula, Arun Arunachalam, Uday Kulkarni, Phaneendra Venkateswara Rao Datari, Sumith Mathew, Aswin Anand PAI, Sushil Selvarajan, Fouzia N., Aby Abraham, Biju George, Poonkuzhali Balasubramanian, Vikram Mathews

Blood (2024) 144 (Supplement 1): 647.

https://doi.org/10.1182/blood-2024-201172

Published: 2024

Journal Articles

EASIX d0 Predicts Early Transplant-Related Mortality in Patients Undergoing Haploidentical Transplantation with Post-Transplant Cyclophosphamide-Mycophenolate Mofetil-Based GvHD Prophylaxis

Aswin Anand Pai, Nieshanth Parthiban, Nayanthara Bijukumar, Rachel Mariam Renji, Manoj A, Sujith Karumathil, Kavitha M Lakshmi, Sushil Selvarajan, Anu Korula, Fouzia NA, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George, Uday Kulkarni, Poonkuzhali Balasubramanian

Blood (2024) 144 (Supplement 1): 4879.

https://doi.org/10.1182/blood-2024-201901

Published: 2024

Journal Articles

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Blood (2023) 142 (Supplement 1): 5513.

https://doi.org/10.1182/blood-2023-184564

Published: 2023

Journal Articles

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Vikram Mathews, Uday Kulkarni, Sushil Selvarajan, Nutan Damodar Joshi, Fouzia NA, Anu Korula, Sharon Anbumalar Lionel, Kavitha M Lakshmi, Alok Srivastava, Biju George, Aby Abraham

Blood (2023) 142 (Supplement 1): 4907.

https://doi.org/10.1182/blood-2023-188868

Published: 2023

Journal Articles

A Model-Informed Precision Busulfan Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation- Real-World Data

Poonkuzhali Balasubramanian, Aswin Anand PAI, Rajesh Nagarajan, Stephanie Hughes, Eunice Sindhuvi Edison, Uday Prakash Kulkarni, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George

Blood (2022) 140 (Supplement 1): 4743–4744.

https://doi.org/10.1182/blood-2022-166959

Published: 2022

Journal Articles

Real-World Outcomes for Acute Promyelocytic Leukemia: Need to Address Induction Mortality

Manju Sengar, Hasmukh Jain, Uday Prakash Kulkarni, Vasu Babu Goli, Anu Korula, Prasanna Samuel, Sushil Selvarajan, Lingaraj Nayak, Aby Abraham, Om Prakash, Fouzia N., Saranya Kumaran, Jayashree Thorat, Bhausaheb Bagal, Poonkuzhali Balasubramanian, Dhanlaxmi Shetty, Nikhil Patkar, Biju George, Vikram Mathews

Blood (2022) 140 (Supplement 1): 3244–3245.

https://doi.org/10.1182/blood-2022-167202

Published: 2022

Journal Articles

Intracranial Bleeding in Acute Promyelocytic Leukemia Treated with Arsenic Trioxide-Based Regimens: Impact on Relapse and Survival

Uday Prakash Kulkarni, Sushil Selvarajan, Fouzia NA, Sharon Lionel, Sukesh C Nair, Poonkuzhali Balasubramanian, Thenmozhi Mani, Aby Abraham, Biju George, Vikram Mathews

Blood (2022) 140 (Supplement 1): 8917–8918.

https://doi.org/10.1182/blood-2022-168649

Published: 2022

Journal Articles

Population Pharmacokinetics of Mycophenolic Acid in Haploidentical Transplant Recipients Receiving Post-Transplant Cyclophosphamide Based GvHD Prophylaxis

Aswin Anand PAI, Uday Kulkarni, Binu Susan Mathew, Nayanthara KB, John C Panetta, Sujith Karumathil, Aby Abraham, Vikram Mathews, Biju George, Poonkuzhali Balasubramanian

Blood (2022) 140 (Supplement 1): 10473–10474.

https://doi.org/10.1182/blood-2022-168894

Published: 2022

Journal Articles

Dysregulated Neutrophil Iron Homeostasis in β-Thalassemia Impairs Phagocytosis and Reactive Oxygen Species Production

Sreenithi Santhakumar, Devi V.J, Leo stephen.R, Aruna Barade, Uday Prakash Kulkarni, Biju George, Eunice Sindhuvi

Blood (2021) 138 (Supplement 1): 942.

https://doi.org/10.1182/blood-2021-154482

Published: 2021

Journal Articles

Real World Data of Concurrent Arsenic Trioxide and All-Trans Retinoic Acid with Minimal Use of Anthracycline in the Treatment of Acute Promyelocytic Leukemia

Uday Prakash Kulkarni, Sushil Selvarajan, Sharon Lionel, Mithun Abraham Prakash, Hamenth Kumar Palani, Nithya Balasundaram, Arvind Venkatraman, Anu Korula, Anup J Devasia, Fouzia NA, Nancy Beryl Janet, Sukesh Chandran Nair, Aby Abraham, Thenmozhi Mani, Jeyaseelan Lakshmanan, Arun Kumar Arunachalam, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews

Blood (2021) 138 (Supplement 1): 2338.

https://doi.org/10.1182/blood-2021-146362

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Real-world data of adolescents and young adults with acute lymphoblastic leukemia treated with a modified GMALL protocol in India: Treatment outcomes and challenges

Targeted base editing enables safe and efficient knockout of ELANE for the treatment of ELANE-associated severe congenital neutropenia

Impact of cancer and therapy on the epigenetic landscapes of normal cells: Describing a novel biomarker in survivorship

Role of fludarabine exposure on post-transplant outcomes in high-risk β-thalassemia patients undergoing allogeneic HCT with thiotepa/ fludarabine/ treosulfan conditioning

Clinico-pathological profile and treatment patterns of immune mediated aplastic anemia in resource constrained settings – an analysis from the aplastic anemia registry of India

Higher busulfan cumulative exposure predicts better thalassemia-free survival in patients with beta thalassemia undergoing HCT with busulfan-cyclophosphamide containing conditioning regimen

Safety, Efficacy and Total Cost of Therapy of Decentralized, Point-of-Care Manufactured Anti-CD19 CAR-T Cells for Relapsed or Refractory B Cell Leukemia and Lymphoma: Results from the First Phase 1 Indian Trial (VELCART)

Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification

Danazol and Stanozolol Induce Expression of Pro-Apoptotic Genes

Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma

EASIX d0 Predicts Early Transplant-Related Mortality in Patients Undergoing Haploidentical Transplantation with Post-Transplant Cyclophosphamide-Mycophenolate Mofetil-Based GvHD Prophylaxis

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

A Model-Informed Precision Busulfan Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation- Real-World Data

Real-World Outcomes for Acute Promyelocytic Leukemia: Need to Address Induction Mortality

Intracranial Bleeding in Acute Promyelocytic Leukemia Treated with Arsenic Trioxide-Based Regimens: Impact on Relapse and Survival

Population Pharmacokinetics of Mycophenolic Acid in Haploidentical Transplant Recipients Receiving Post-Transplant Cyclophosphamide Based GvHD Prophylaxis

Dysregulated Neutrophil Iron Homeostasis in β-Thalassemia Impairs Phagocytosis and Reactive Oxygen Species Production

Real World Data of Concurrent Arsenic Trioxide and All-Trans Retinoic Acid with Minimal Use of Anthracycline in the Treatment of Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only